CA946280A - Inhalant powder compositions - Google Patents

Inhalant powder compositions

Info

Publication number
CA946280A
CA946280A CA 26437 CA26437A CA946280A CA 946280 A CA946280 A CA 946280A CA 26437 CA26437 CA 26437 CA 26437 A CA26437 A CA 26437A CA 946280 A CA946280 A CA 946280A
Authority
CA
Grant status
Grant
Patent type
Prior art keywords
powder compositions
inhalant powder
inhalant
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA 26437
Inventor
Philip S. Hartley
Stephen R. Gunning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Pharmaceuticals Ltd
Original Assignee
GUNNING, STEPHEN R.
HARTLEY, PHILIP S.
Fisons Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/826Asthma
CA 26437 1967-08-08 1968-08-01 Inhalant powder compositions Expired CA946280A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3627067A GB1242211A (en) 1967-08-08 1967-08-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
CA946280A true CA946280A (en) 1974-04-30

Family

ID=10386572

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 26437 Expired CA946280A (en) 1967-08-08 1968-08-01 Inhalant powder compositions

Country Status (10)

Country Link
US (1) US3634582A (en)
JP (1) JPS5643448B1 (en)
BE (1) BE718846A (en)
CA (1) CA946280A (en)
DE (2) DE1792207C3 (en)
DK (1) DK123276B (en)
FI (1) FI48973C (en)
FR (2) FR8142M (en)
GB (1) GB1242211A (en)
NL (1) NL161984C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787100A (en) * 1971-08-06 1973-02-02 Beecham Group Ltd A composition for the treatment of asthma
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
DE2332663C2 (en) * 1973-06-23 1986-07-31 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
DE2535258C2 (en) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk, Gb
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
FI770215A (en) * 1976-01-30 1977-07-31 Fisons Ltd
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
BE891013A (en) * 1980-11-05 1982-05-05 Fisons Ltd pharmaceutical compositions
JPS6237016B2 (en) * 1983-03-09 1987-08-10 Teijin Ltd
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
DE3872635D1 (en) * 1987-04-09 1992-08-13 Fisons Plc Pentamidine pharmaceutical compositions containing them.
DE4140689B4 (en) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalation powders and methods for their preparation
CA2115444C (en) * 1992-06-12 2000-10-03 Yuji Makino Preparation for intratracheobronchial administration
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
ES2166786T3 (en) * 1993-10-01 2002-05-01 Astrazeneca Ab Procedure i.
RU2170083C2 (en) 1993-10-01 2001-07-10 Астра Актиеболаг Medical preparation and method and device for processing and producing the preparation
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
NL9301851A (en) * 1993-10-26 1995-05-16 Cordis Europ Cryo-ablation catheter.
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (en) * 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
CN1170527C (en) 1994-12-22 2004-10-13 阿斯特拉公司 Therapeutic perparation for inhalation containing parathyroid hormone, PTH
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE69825995D1 (en) * 1997-05-27 2004-10-07 Direct Haler As Odense An inhaler for powdered medications
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
ES2310047T3 (en) 1998-08-18 2008-12-16 The Regents Of The University Of California Antagonists epidermal growth factor receptor for the treatment of hypersecretion of mucus in the lungs.
DE60030721T2 (en) 1999-07-16 2007-09-13 Chiesi Farmaceutici S.P.A. Powder particles with a smooth surface for use in inhalation therapy
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
EP1276472B1 (en) 2000-04-17 2006-12-20 Vectura Limited Formulations for use in inhaler devices
ES2259046T5 (en) 2000-10-12 2011-02-28 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Process for producing formulations in powder form.
CA2395653C (en) * 2000-10-12 2006-05-09 Boehringer Ingelheim Pharma Kg New inhalable powder containing tiotropium
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
DE10141377A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Sprinkling method for preparation of powder formulations
JP2005507881A (en) * 2001-09-17 2005-03-24 グラクソ グループ リミテッドGlaxo Group Limited Dry powder pharmaceutical formulations
WO2003043574A3 (en) * 2001-11-19 2004-03-04 Becton Dickinson Co Pharmaceutical compositions in particulate form
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US6900317B2 (en) * 2002-02-19 2005-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
US20040014679A1 (en) * 2002-02-20 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co., Kg Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
DE10207026A1 (en) * 2002-02-20 2003-08-28 Boehringer Ingelheim Kg Stable inhalable powder of the calcitonin gene-related peptide antagonist, BIBN4096, useful for treating migraine, in the form of spherical nano-structured particles obtained by spray-drying
JP2006516531A (en) * 2002-08-21 2006-07-06 ノートン ヘルスケアー リミテッドNorton Healthcare Ltd. Inhalation composition
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium containing powder formulation for inhalation
DE10317461A1 (en) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
US20050042178A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N2- [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxochinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, processes for its preparation and its use as Inhalativum
DE10338407A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg New Inhalation powder containing the CGRP antagonist 1- [N2- [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxochinazolin-3-yl) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine
US20050042179A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
US20050043247A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative
DE10338402A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried, amorphous BIBN 4096, process for its preparation and its use as Inhalativum
ES2362038T3 (en) 2003-09-02 2011-06-27 Norton Healthcare Limited Process for preparing a medicament.
ES2390458T3 (en) 2003-11-04 2012-11-13 Glaxo Group Limited Muscarinic antagonists acetylcholine M3 receptor
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
CA2755954C (en) 2004-04-27 2014-02-18 Glaxo Group Limited Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists
US7723306B2 (en) * 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7727962B2 (en) * 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7611709B2 (en) * 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
DE102004048389A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifying surfaces of lactose as an excipient for use in powdered inhalants
DE102004048390A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg New inhalation powders based on modified lactose mixtures as an adjuvant
CN104177448A (en) * 2005-02-10 2014-12-03 葛兰素集团有限公司 Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom
CN103145766B (en) 2008-07-24 2015-02-11 乔治洛德方法研究和开发液化空气有限公司 Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films
WO2013104892A8 (en) 2012-01-13 2013-09-19 Hovione Inter Limited Application of high dose compounds via inhalation
US20150165038A1 (en) * 2012-02-10 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and sorbitol
WO2014007769A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and glucose anhydrous

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1489749A (en) * 1965-03-25 1967-07-28 Fisons Pharmaceuticals Ltd A process for preparing bis-chromonylés and their derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler

Also Published As

Publication number Publication date Type
BE718846A (en) 1969-01-31 grant
FR8142M (en) 1970-08-17 grant
FI48973C (en) 1975-03-10 grant
DE1792799A1 (en) 1977-08-11 application
FI48973B (en) 1974-12-02 application
CA946280A1 (en) grant
FR1605538A (en) 1979-02-23 grant
GB1242211A (en) 1971-08-11 application
DE1792207A1 (en) 1971-11-04 application
DK123276B (en) 1972-06-05 grant
DE1792207B2 (en) 1977-10-13 application
NL161984B (en) 1979-11-15 application
US3634582A (en) 1972-01-11 grant
NL161984C (en) 1980-04-15 grant
NL6811060A (en) 1969-02-11 application
JPS5643448B1 (en) 1981-10-13 grant
DE1792207C3 (en) 1978-06-29 grant

Similar Documents

Publication Publication Date Title
CA971184A (en) Aliphatic isocyanate compositions
CA764537A (en) Fluoroelastomer adhesive compositions
CA849491A (en) Compositions containing lithium compounds
CA703607A (en) Herbicidal compositions
CA745682A (en) Thermosetting compositions
CA784639A (en) Herbicidal compositions
CA761048A (en) Foamable compositions
CA732653A (en) Coating compositions
CA753207A (en) Antiseptic compositions
CA703594A (en) Asphalt-copolymer composition
CA930669A (en) Compositions anti-acneiques
CA879600A (en) Explosive pellet composition
GB1167756A (en) Terrazo Composition
CA918569A (en) Perfumery compositions
CA987499A (en) Ignitable compositions
CA989194A (en) Herbicidal compositions
CA955820A (en) Azeotropic composition
CA921188A (en) Polyvinyl-aromatic compositions and the manufacture thereof
CA1009151A (en) Composition cosmetique
CA761049A (en) Foamable compositions
CA964191A (en) Anti-malarial compositions containing substituted diamino-triazines
CA694514A (en) Gelatin-polyether compositions
CA708663A (en) Hot-melt resinous compositions
CA678353A (en) Cardiac-active pharmaceutical compositions
CA702753A (en) Branched-chain alcohol compositions